Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
Go back to Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation| (NASDAQ: ESLA) | Delayed: 0.49 -0.01 (2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $ | |||
| Open | $0.55 | 52 Week Low | $ | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $ | |||
| Volume | 62,630 | |||||
